World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
106
Citations
50611
World Ranking
6432
National Ranking
623

Overview

Peter Hoskin is affiliated with the University of Manchester in the United Kingdom. Their research primarily falls within the broad field of Medicine, with focused contributions to Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Surgery, Radiation, and Obstetrics and Gynecology.

Their work covers several major topics related to cancer treatment and radiotherapy. These include Advanced Radiotherapy Techniques, Prostate Cancer Diagnosis and Treatment, Endometrial and Cervical Cancer Treatments, Management of metastatic bone disease, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, and Radiomics and Machine Learning in Medical Imaging.

Peter Hoskin has co-authored frequently with several researchers in their field. Notable frequent collaborators include Ananya Choudhury, Catharine West, Kari Tanderup, Bradley R. Pieters, and Richard Pötter.

Publications by Peter Hoskin have appeared most frequently in the following journals and venues:

  • Radiotherapy and Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Clinical Oncology
  • Annals of Palliative Medicine
  • Brachytherapy

Recent papers authored or co-authored by Peter Hoskin include:

  • "MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study" (2021) published in The Lancet Oncology
  • "Sarcopenia in cancer: Risking more than muscle loss" (2020) published in Technical Innovations & Patient Support in Radiation Oncology
  • "European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus on re-irradiation: definition, reporting, and clinical decision making" (2022) published in The Lancet Oncology
  • "Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials" (2021) published in The Lancet Oncology
  • "Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial" (2022) published in PLoS Medicine

Best Publications

  • Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

    C. Parker;S. Nilsson;S. Nilsson;D. Heinrich;S. I. Helle

  • Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy

    Nicholas D. James;Johann S. de Bono;Melissa R. Spears;Noel W. Clarke

  • The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

    Bentzen Sm;Agrawal Rk;Aird Eg

  • Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline.

    Stephen Lutz;Lawrence Berk;Eric Chang;Edward Chow

  • The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.

    Bentzen Sm;Agrawal Rk;Aird Eg

  • Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines.

    M Fallon;R Giusti;F Aielli;P Hoskin

  • Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting

    Louise Dickinson;Louise Dickinson;Louise Dickinson;Hashim U. Ahmed;Hashim U. Ahmed;Clare Allen;Jelle O. Barentsz

  • The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies

    Richard Pötter;Kari Tanderup;Christian Kirisits;Astrid de Leeuw

  • Results of a trial of PET-directed therapy for early-stage Hodgkin's lymphoma.

    John Radford;Tim Illidge;Nicholas Counsell;Barry Hancock

  • Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study.

    Alina Sturdza;Richard Pötter;Lars Ulrik Fokdal;Christine Haie-Meder

  • Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomised controlled trial.

    KM Ardeshna;P Smith;A Norton;BW Hancock

  • Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, randomised trial

    Oliver Sartor;Robert E Coleman;Sten Nilsson;Daniel Heinrich

  • Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

    Stephanie M. de Boer;Melanie E. Powell;Linda Mileshkin;Dionyssios Katsaros

  • Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases.

    P. Price;P.J. Hoskin;D. Easton;D. Austin

  • Randomised trial of external beam radiotherapy alone or combined with high-dose-rate brachytherapy boost for localised prostate cancer

    Peter J. Hoskin;Ana M. Rojas;Peter J. Bownes;Gerry J. Lowe

  • Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study

    Anthony J. Swerdlow;Craig D. Higgins;Paul Smith;David Cunningham

  • Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019)

    Nicholas David James;Melissa R. Spears;Noel W. Clarke;David P. Dearnaley

  • Non-Small Cell Lung Cancer: Histopathologic Correlates for Texture Parameters at CT

    Balaji Ganeshan;Vicky Goh;Henry C. Mandeville;Quan Sing Ng

  • Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespecified subgroup analysis from the randomised, double-blind, phase 3 ALSYMPCA trial

    Peter Hoskin;Oliver Sartor;Joe M O'Sullivan;Dag Clement Johannessen

  • Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    Stephanie M de Boer;Melanie E Powell;Linda Mileshkin;Dionyssios Katsaros

Frequent Co-Authors

Richard Pötter
Richard Pötter Medical University of Vienna
Edward Chow
Edward Chow Sunnybrook Health Science Centre
Christine Haie-Meder
Christine Haie-Meder Institut Gustave Roussy
Catharine M L West
Catharine M L West University of Manchester
Anwar R. Padhani
Anwar R. Padhani Northwood University
Chris Parker
Chris Parker Institute of Cancer Research
David C. Linch
David C. Linch University College London
Steven E. Schild
Steven E. Schild Mayo Clinic
John Yarnold
John Yarnold Institute of Cancer Research
Søren M. Bentzen
Søren M. Bentzen University of Maryland, Baltimore

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in studying Medicine in the USA, there are several related online degrees and career pathways to consider. These programs can help you gain vital skills in the healthcare field, often with flexible study options that fit your schedule.

For those aiming to start or advance a nursing career, absn programs that don't require teas offer a streamlined path to becoming a nurse without the added requirement of standardized entrance exams. Nurses looking to take the next step may benefit from rn to np bridge programs, which allow registered nurses to efficiently progress towards advanced practice roles.

If your interests lie in the business side of healthcare, consider earning an accelerated healthcare administration degree. These programs prepare you for leadership positions in hospitals and medical organizations. Additionally, a passion for wellness and patient nutrition can be pursued through online degrees in nutrition, opening doors to roles in clinical nutrition, public health, and more.

Best Scientists Citing Peter Hoskin

Trending Scientists

Recently Published Articles